Ana Beloqui at Université catholique de Louvain - Research Interests, Publications & Academic Profile

Ana Beloqui

Assistant Professor

Université catholique de Louvain

Belgium

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

Send an email

ORCID

Google Scholar

Research Interests

Pharmacology

70%

Clinical Nutrition

50%

Drug Delivery

60%

Diabetology

40%

Intestinal Biology

40%

Nanomedicine

30%

Mucosal Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

NanoGut

Open Date: 2020-01-01

Close Date: 2024-12-01

Articles16

Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention

Article Link

Year:

2024

Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease

Article Link

Year:

2024

A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment

Article Link

Year:

2024

“Green” synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokinetics

Article Link

Year:

2024

Poly-ɛ-caprolactone nanocapsules loaded with copaiba essential oil reduce inflammation and pain in mice

Article Link

Year:

2023

"Green"-synthesized zinc oxide nanoparticles and plant extracts: A comparison between synthesis processes and antihyperglycemic activity

Article Link

Year:

2023

Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease

Article Link

Year:

2023

Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery

Article Link

Year:

2023

Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat.

Article Link

Year:

2022

An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations

Article Link

Year:

2022

Surface Modification of Lipid-Based Nanoparticles

Article Link

Year:

2022

Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation

Article Link

Year:

2022

Impact of PEGylation on antibody-loaded nanoparticulate drug delivery system on treatment of inflammatory bowel disease

Article Link

Year:

2021

Quality-by-Design-Based Development of a Voxelotor Self-Nanoemulsifying Drug-Delivery System with Improved Biopharmaceutical Attributes

Article Link

Year:

2021

An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers

Article Link

Year:

2021

Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment

Article Link

Year:

2021

Collaborators8

Julien Prevost

Université catholique de Louvain

BELGIUM

Nathalie Delzenne

full professor - Research coordinator of Health Sector

UCLouvain

BELGIUM

Joëlle Leclercq

Full Professor

Université catholique de Louvain

BELGIUM

Dominic-Luc Webb

AA, AS, BS, PhD, Associate Professor of Experimental Gastroenterology, supervisor

SWEDEN

Ellen Andersson

SWEDEN

Per Artursson

Uppsala University

SWEDEN

Giulio Muccioli

Professor

Université catholique de Louvain

BELGIUM

Laure B. Bindels

Assistant Professor

Université catholique de Louvain

BELGIUM

How do I reach out?

Meet Kite AI